Jordan Julie — SEC Form 4 filings

SEC reporting owner CIK 1968554. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-30.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-01-18 to 2026-03-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Neurogene Inc. (NGNE)Chief Medical Officer41 leg · 828 sh · $18,1285

Form 4 filings — Jordan Julie

FiledFormIssuerReported transactionsSource
2026-03-304Neurogene Inc. (NGNE)Sale (S): 828 @ $21.89EDGAR
2026-02-244Neurogene Inc. (NGNE)Grant/award (A): 4,900 @ $0 · Grant/award (A): 29,600 (derivative) @ $0EDGAR
2025-03-284Neurogene Inc. (NGNE)Grant/award (A): 8,400 @ $0 · Grant/award (A): 50,300 (derivative) @ $0EDGAR
2024-01-184Neurogene Inc. (NGNE)Grant/award (A): 75,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1968554 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →